scholarly journals Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18–64 years in the USA

2016 ◽  
Vol 1 (1) ◽  
pp. 8-15 ◽  
Author(s):  
Heesoo Joo ◽  
Guijing Wang ◽  
Mary G George
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Hospital Costs ◽  
Intravenous Tissue Plasminogen Activator ◽  
Tissue Plasminogen ◽  
The Usa

Outcomes of intravenous tissue plasminogen activator for acute ischaemic stroke in HIV-infected adults

2014 ◽  
Vol 21 (11) ◽  
pp. 1394-1399 ◽  
Author(s):  
E. M. Sweeney ◽  
K. T. Thakur ◽  
J. L. Lyons ◽  
B. R. Smith ◽  
J. Z. Willey ◽  
...  
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Intravenous Tissue Plasminogen Activator ◽  
Tissue Plasminogen

scholarly journals GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance

2021 ◽  
pp. svn-2020-000633
Author(s):  
Suxi Zheng ◽  
Tian Jie Lyu ◽  
Zixiao Li ◽  
Hongqiu Gu ◽  
Xin Yang ◽  
...  
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Emergency Services ◽  
Influential Factors ◽  
Adherence Rate ◽  
Intravenous Tissue Plasminogen Activator ◽  
Tissue Plasminogen ◽  
Per Capita ◽  
Stroke Center

BackgroundTimely delivery of intravenous tissue plasminogen activator (IV-rt PA) is pivotal to eligible patients who had a stroke while achieving higher rates of IV-rt PA has been problematic. This paper focuses on investigating influential factors associated with the administration of IV-rt PA, primarily per capita gross regional product (GRP) and healthcare system factors.MethodsThe study included 980 hospitals in the Chinese Stroke Center Alliance where 158 003 patients who had an acute ischaemic stroke received IV-rt PA between August 2015 and August 2019. The adherence rate to IV-rt PA within 4.5 hours time window in each hospital was the primary outcome. Influential factors were grouped into two categories: macroeconomic status and hospital characteristics. The outcome was analysed using multivariable linear regression.ResultsGRP per capita (β=2.37, p<0.001), hospital stroke centre certification (β=3.77, p<0.001), number of neurologists (β=0.12, p<0.001), existence of emergency services for neurological treatment (β=7.43, p=0.014), presence of emergency department (β=10.03, p=0.019) and cooperating with emergency centre (β=4.65, p=0.029) were significantly positively associated with the adherence rate to IV-rt PA.ConclusionsHigher GRP per capita, affluent neurological personnel, well-equipped emergency services for neurological treatment and routine cooperation with the emergency centre were important for enhancing the adherence rate to IV-rt PA among patients who had an acute ischaemic stroke in China.

Tissue-plasminogen activator for acute ischaemic stroke

The Lancet ◽  
1997 ◽  
Vol 349 (9050) ◽  
pp. 504
Author(s):  
Paul Dorman ◽  
Peter Sandercock
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Tissue Plasminogen

Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

2001 ◽  
Vol 19 (9) ◽  
pp. 927-936 ◽  
Author(s):  
Shannon E. Sinclair ◽  
Luciana Frighetto ◽  
Peter S. Loewen ◽  
Rubina Sunderji ◽  
Philip Teal ◽  
...  
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Tissue Plasminogen
Sign in / Sign up

Export Citation Format

Share Document